Clinical Trials
6 trialsNCT06779318 2025-04-03
Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis
The First Affiliated Hospital with Nanjing Medical University
Phase 4 Not yet recruiting
NCT06169410 2024-01-23
Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer
Xijing Hospital
Phase 4 Unknown
NCT04217096 2020-01-03
Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients
Fudan University
Phase 4 Unknown
NCT02945267 2016-10-26
Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer
Chinese PLA General Hospital
Phase 4 Unknown
NCT01997957 2013-11-28
SOON
Peking University Cancer Hospital & Institute
Phase 4 Unknown
NCT01849380 2013-05-08
Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer
Shandong University
Phase 4 Unknown